An Emerging Technique for Measurable Residual Disease (MRD) Detection inAcute Myeloid Leukemia
Webinar presenter, Jerald Radich, MD, Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Center, discusses the latest research on MRD in acute myeloid leukemia and techniques for MRD detection, the implications of MRD in disease progression, prognosis and therapy selection, challenges of traditional MRD testing methods, the medical guidelines, and why NGS is emerging as a powerful technique for MRD detection. Moderated by: Bob McGonnagle, Publisher, CAP TODAY. This on-demand webinar originally broadcast September 27, 2022.